Model Number 305C25 |
Device Problems
Torn Material (3024); Insufficient Information (3190)
|
Patient Problems
Aortic Insufficiency (1715); Calcium Deposits/Calcification (1758); Prolapse (2475); No Information (3190)
|
Event Date 11/07/2013 |
Event Type
Injury
|
Manufacturer Narrative
|
Without the return of the product, no definitive conclusion can be made regarding the clinical observation.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that 8 years 6 days post implant of this aortic bioprosthetic valve, the device was replaced due to unknown reasons.No additional adverse patient effects were reported. .
|
|
Manufacturer Narrative
|
Medtronic received additional information that 8 years 6 days post implant of this aortic bioprosthetic valve, the device was replaced a transesophageal echocardiogram (tee) was performed which demonstrated severe aortic prosthetic valve malfunction.It appeared that one of the leaflets prolapsed into the ventricle with resultant severe aortic insufficiency.The intraoperative findings revealed a significant amount of adhesion from the previous surgery.The ascending aorta and root were aneurysmally enlarged.Visualization of the valve revealed calcification of the leaflets with the tear of the leaflet at the non-coronary side and prolapsed into the ventricle.It was obvious there was calcium debrided off the undersurface of the anterior mitral leaflet at the time of the first surgery.The character of the ascending aorta was aneurysmal and the wall attenuated.The previously implanted valve was excised and the annulus was debrided of the additional pledget material and sized to fit a 25 mm prosthesis.The 25 mm aortic bioprosthetic valve was implanted and the patient was weaned off of cardiopulmonary bypass.The heart was then inspected with a transesophageal echocardiogram (tee) and satisfactory function was noted.No additional adverse patient effects were reported. if information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|